SelectScience
Join Free
Accelerating Science
NewsLife Sciences

CAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma

SelectScience

Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape

6 Oct 2020
Tom Casburn
Associate Editor

Expert insights

Carlos Fernández de Larrea, University of Barcelona and Rogier M. Reijmers, LUMICKS

There have been significant advances in how we treat relapsed multiple myeloma within the past decade, which in turn has resulted in more effective treatments and an increase in survival rates. A very promising and novel approach is the application of chimeric antigen receptor (CAR) T cells, which have already demonstrated unprecedented clinical successes in the treatment of pediatric lymphoblastic leukemia. CAR-T cell therapy for myeloma targeting BCMA has shown high response rates, however, relapses remain. It has been found that myeloma cells lacking sufficient BCMA surface expression may be associated with relapse episodes, since these cells can escape immunity. A solution to prevent immune escape could be the simultaneous targeting of a second antigen.

In this SelectScience webinar, hear from experts Dr. Carlos Fernández de Larrea, Associate Professor of Medicine at the University of Barcelona, and Dr. Rogier M. Reijmers, Principle Scientist at LUMICKS, to find out how targeting BCMA and GPRC5D simultaneously with T cells engineered to express CARs specific for these antigens may prevent tumor cell escape, resulting in improved survival rates and short-term tumor reduction. Also discover how bicistronic edited CAR-T cells are showing higher interaction force with target cells using the LUMICKS’ z-Movi® Cell Avidity Analyzer, suggesting that this "multi-valent" approach is responsible for the enhanced activity in vivo.

Register Now

Watch this webinar to learn:

  • New strategies to prevent antigen loss immune escape
  • How CAR vector design and configuration can increase in vivo efficacy
  • Why avidity could predict increased efficacy of CAR-T cell products

Who should attend?

  • Researchers with a strong interest in developing new immunotherapies against cancer using bispecific antibodies, CAR-T cells, NK cells, TCR T cells, allogeneic T cells, or other similar strategies.

The live webinar takes place on Monday, October 19 at:

  • 16:00 BST
  • 11:00 EDT
  • 08:00 PDT
  • 17:00 CEST

SelectScience runs 10+ webinars a month across various scientific topics, discover more of our upcoming webinars>>

Links

SelectScienceCompany website

Tags

Cell Lines Stem Cells and Primary CellsPrimary cell cultures, established cell lines and stem cells are vital for <i>in vitro</i> and <i>ex vivo</i> experimentation. High-quality cells, optimized for your applications, alongside optimized cell substrates, growth medium and supplements, are critical for experimental success. Explore a range of cells suitable for your applications, including isogenic cell lines, competent cells, induced pluripotent stem cell (iPSC)-derived cell lines, fungal/bacterial/mammalian cell lines, stem cells and cancer cell lines. Find the best cells for your research in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Gene Expression and Molecular CloningMolecular cloning is a set of techniques that utilizes vectors to transfer recombinant DNA into host cells and is an essential tool for investigating the expression of genes and proteins in bacterial or mammalian cells. A variety of vectors optimized for gene cloning and expression in a range of host organisms are available, alongside competent cells for genetic replication. Here, you can explore a range of molecular tools, high-quality genomic and cDNA libraries, premade clones, transformation and transfection reagents and mutagenesis or gene expression detection assays and expression arrays. Find the best gene expression and molecular cloning products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Cell TherapyCell therapy involves using living cells to treat diseases, often by replacing damaged cells or stimulating regeneration. Stem cell therapy and CAR-T cell therapy are examples of cutting-edge treatments in regenerative medicine and cancer immunotherapy. Browse our peer-reviewed product directory to find the best cell therapy tools, compare products, check reviews, and get pricing directly from manufacturers.MyelomaMultiple MyelomaTumorsTumor research focuses on understanding abnormal cell growth that leads to cancer. Identifying biomarkers, studying tumor microenvironments, and developing targeted therapies are critical for advancing cancer treatment. Early detection and personalized treatment options are key to improving outcomes for patients. Browse our peer-reviewed product directory to explore tools for tumor research, diagnostics, and cancer therapies; compare products, read customer reviews, and get pricing directly from manufacturers.WebinarT Cells

Related articles

CAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma